| 产品名称 | 产品编号 | CAS编号 | 分子式 = 分子量 | 位单 | 联系QQ |
| 岩大戟内酯A; Jolkinolide A | CFN92871 | 37905-07-0 | C20H26O3 = 314.4 | 5mg | QQ客服：2159513211 |
| 岩大戟内酯E; Jolkinolide E | CFN92872 | 54494-34-7 | C20H28O2 = 300.4 | 5mg | QQ客服：1457312923 |
| 月腺大戟素A; Ebracteolatanolide A | CFN92873 | 212563-72-9 | C20H28O4 = 332.4 | 5mg | QQ客服：2056216494 |
| 月腺大戟素D; Yuexiandajisu D | CFN92874 | 866556-15-2 | C20H30O5 = 350.4 | 5mg | QQ客服：3257982914 |
| 月腺大戟素E; Yuexiandajisu E | CFN92875 | 866556-16-3 | C20H30O5 = 350.4 | 5mg | QQ客服：2056216494 |
| Hugorosenone; Hugorosenone | CFN92876 | 217096-49-6 | C20H30O2 = 302.4 | 5mg | QQ客服：2056216494 |
| Jolkinol A; Jolkinol A | CFN92878 | 62820-11-5 | C29H36O6 = 480.6 | 5mg | QQ客服：2159513211 |
| Fischeria A; Fischeria A | CFN92879 | 221456-63-9 | C19H28O2 = 288.4 | 5mg | QQ客服：2056216494 |
| 大戟因子L1; Euphorbia factor L1 | CFN92883 | 76376-43-7 | C32H40O8 = 552.7 | 20mg | QQ客服：1457312923 |
| 大戟因子L2; Euphorbia factor L2 | CFN92884 | 218916-51-9 | C38H42O9 = 642.7 | 20mg | QQ客服：215959384 |
| 大戟因子L7a; Euphorbia factor L7a | CFN92885 | 93550-94-8 | C33H40O7 = 548.7 | 20mg | QQ客服：1457312923 |
| 大戟因子L8; Euphorbia factor L8 | CFN92886 | 218916-53-1 | C30H37NO7 = 523.6 | 10mg | QQ客服：1413575084 |
| 大戟因子L9; Euphorbia factor L9 | CFN92887 | 129393-28-8 | C37H41NO9 = 643.7 | 5mg | QQ客服：2159513211 |
| 3 Beta-巴豆酰基氧基-等效-贝壳杉-16-烯酸; ent-3Beta-Tigloyloxykaur-16-en-19-oic acid | CFN97869 | 79406-09-0 | C25H36O4 = 400.6 | 5mg | QQ客服：2159513211 |
| 对映-3beta-当归酰基氧基-16-贝壳杉-19-烯酸; ent-3Beta-Angeloyloxykaur-16-en-19-oic acid | CFN97870 | 74635-61-3 | C25H36O4 = 400.6 | 5mg | QQ客服：2159513211 |
Cell. 2018 Jan 11;172(1-2):249-261.e12. doi: 10.1016/j.cell.2017.12.019.IF=36.216(2019)
Cell Metab. 2020 Mar 3;31(3):534-548.e5. doi: 10.1016/j.cmet.2020.01.002.IF=22.415(2019)
Mol Cell. 2017 Nov 16;68(4):673-685.e6. doi: 10.1016/j.molcel.2017.10.022.IF=14.548(2019)
ACS Nano. 2018 Apr 24;12(4): 3385-3396. doi: 10.1021/acsnano.7b08969.IF=13.903(2019)
Nature Plants. 2016 Dec 22;3: 16206. doi: 10.1038/nplants.2016.205.IF=13.297(2019)
Sci Adv. 2018 Oct 24;4(10): eaat6994. doi: 10.1126/sciadv.aat6994.IF=12.804(2019)